Clinical · Molecular biology
The landscape of peripheral blood RNA modifications and its clinical implications for diagnosis of hepatocellular carcinoma
This study investigated the landscape of RNA modifications in the peripheral blood of patients with hepatocellular carcinoma (HCC), liver cirrhosis, and healthy controls. Using liquid chromatography-tandem mass spectrometry, 55 RNA modifications were quantified, revealing 11 significantly altered modifications in HCC patients, including those at stage I. N2,N2-dimethylguanosine (m2,2G) emerged as the most profoundly dysregulated. A diagnostic model based on a panel of modifications including m2,2G, combined with IFI27 and CCR2 gene expression, demonstrated promising diagnostic performance for HCC, especially for early stages, with high AUCs. These findings suggest the potential for novel diagnostic biomarkers for HCC.